An international collaboration led by chemists and engineers from the University of Pennsylvania has prepared a library of synthetic biomaterials that mimic cellular membranes and that show promise in targeted delivery of ...
Bio & Medicine
May 20, 2010
0
0
More than 200 mobile apps for diagnosing skin rashes and moles are now on the market, and US researchers Wednesday urged caution in relying on them over a doctor's advice.
Software
Sep 25, 2013
0
0
In the fight against cancer, knowing the enemy's exact identity is crucial for diagnosis and treatment, especially in metastatic cancers, those that spread between organs and tissues. Now chemists led by Vincent Rotello at ...
Analytical Chemistry
Sep 13, 2012
1
0
In the EU project ENEFRF, researchers at the Ångström Laboratory are working on improving the radio frequency amplifiers that will make technology for cancer diagnostics more efficient, accessible, and affordable. "We are ...
General Physics
Oct 11, 2018
0
3
Cancer diagnosis has come a long way, with noninvasive diagnostic imaging largely replacing exploratory surgery. At UWM, physicist Sarah Patch is working on the next generation of diagnostic tools: thermoacoustic imaging.
General Physics
Jan 29, 2016
0
20
A fast, inexpensive yet sensitive technique to detect cancer markers is bringing researchers closer to a "liquid biopsy"—a test using a small sample of blood or serum to detect cancer, rather than the invasive tissue sampling ...
Biochemistry
Dec 18, 2019
0
627
By giving living cells a "nano-poke" and monitoring the resulting changes in the intracellular environment, researchers have gotten their first glimpse of how whole cells respond to external mechanical pressure.
Bio & Medicine
Nov 21, 2023
0
78
Testing the effectiveness of new pharmaceuticals may get faster thanks to a new technique incorporating quantum dots developed at the University of Central Florida.
Bio & Medicine
Dec 19, 2011
0
0
(PhysOrg.com) -- A team of Northwestern University researchers, using an extremely sensitive nanotechnology-based tool known as the biobarcode system, has detected previously undetectable levels of prostate-specific antigen ...
Bio & Medicine
Nov 18, 2009
1
0
Shares of diagnostic test maker Myriad Genetics Inc. are jumping Thursday after the Supreme Court issued a mixed ruling in a case involving the company's patents on genes at the center of its tests for increased risk of breast ...
Business
Jun 13, 2013
0
0
